11.6 billion dollar market for colorectal treatments by 2016.
However, unmet needs with respect to severe adverse effects and unconvincing safety data associated with these treatments are therefore, enhancing opportunities for market expansion of novel drugs that focus on improved safety and efficacy. With escalating awareness, Asian countries are increasingly demanding for novel drugs and therapies than ever before. The above factors are demanding R&D focus among the pharmaceutical companies.
However, unmet needs with respect to severe adverse effects and unconvincing safety data associated with these treatments are therefore, enhancing opportunities for market expansion of novel drugs that focus on improved safety and efficacy. With escalating awareness, Asian countries are increasingly demanding for novel drugs and therapies than ever before. The above factors are demanding R&D focus among the pharmaceutical companies.
Recent PRPO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2026 08:00:21 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/19/2026 06:19:44 PM
- Precipio Announces Q1 2026 Financial Results • GlobeNewswire Inc. • 05/14/2026 09:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:16:28 PM
- Management team’s 2025 market-based Options have vested • GlobeNewswire Inc. • 05/13/2026 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 09:15:42 PM
- Precipio Announces Q1-2026 Shareholder Update Call • GlobeNewswire Inc. • 05/06/2026 09:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/28/2026 08:32:35 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/28/2026 08:31:36 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/28/2026 08:30:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 09:01:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 09:00:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 08:59:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 08:00:09 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:34:59 PM
- Precipio Announces Q4 and year-end 2025 Shareholder Update Call • GlobeNewswire Inc. • 03/12/2026 09:00:00 PM
- Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 Assay • GlobeNewswire Inc. • 03/10/2026 01:00:00 PM
- Precipio 2025 (Unaudited) Revenues Grew to $24.0M, a 30% Increase Year-Over-Year • GlobeNewswire Inc. • 02/25/2026 02:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/26/2026 10:08:49 PM
